Ann: Imagion Biosystems December 2021 Investor Newsletter, page-16

Disapointing to still be kept in the dark re enrolments however based on the last 12 months I was fully prepared for that.
I don't expect trial results until the back half of the 3rd qtr at the earliest and there is now a risk that Omicron could throw a spanner in those works.
Any negative outcomes from trials would have been reported and haven't so that's a plus.
Whether they are getting the positive results we hope for is the multi million dollar question.
I've been in this stock for over 4 years, another 4 months for an endorsement of my patience I can deal with.